ABEIXI™
生化试剂
| SP-MHCI-1144-2 | NY-ESO 1 165-179, CFLPVFLAQPPSGQR |
| SP-MHCI-1144-3 | NY-ESO 1 165-179, CFLPVFLAQPPSGQR |
| SP-MHCI-1145-2 | NY-ESO 2 25-39, DGPGGNAGGPGEAGA |
| SP-MHCI-1145-3 | NY-ESO 2 25-39, DGPGGNAGGPGEAGA |
| SP-MHCI-1146-2 | NY-ESO 1 89-103, EFYLAMPFATPMEAE |
| SP-MHCI-1146-3 | NY-ESO 1 89-103, EFYLAMPFATPMEAE |
| SP-MHCI-1147-2 | NY-ESO 1 49-63, GAARASGPGGGAPRG |
| SP-MHCI-1147-3 | NY-ESO 1 49-63, GAARASGPGGGAPRG |
| SP-MHCI-1148-2 | NY-ESO 1 57-71, GGGAPRGPHGGAASG |
| SP-MHCI-1148-3 | NY-ESO 1 57-71, GGGAPRGPHGGAASG |
| SP-MHCI-1149-2 | NY-ESO 2 41-55, GGRGPRGAGAARASG |
| SP-MHCI-1149-3 | NY-ESO 2 41-55, GGRGPRGAGAARASG |
| SP-MHCI-1150-2 | NY-ESO 2 9-23, GGSTGDADGPGGPGI |
| SP-MHCI-1150-3 | NY-ESO 2 9-23, GGSTGDADGPGGPGI |
| SP-MHCI-1151-2 | NY-ESO 1 149-163, ISSCLQQLSLLMWIT |
| SP-MHCI-1151-3 | NY-ESO 1 149-163, ISSCLQQLSLLMWIT |
| SP-MHCI-1152-2 | NY-ESO 1 153-167, LQQLSLLMWITQCFL |
| SP-MHCI-1152-3 | NY-ESO 1 153-167, LQQLSLLMWITQCFL |
| SP-MHCI-1153-2 | NY-ESO 1 137-151, LTAADHRQLQLSISS |
| SP-MHCI-1153-3 | NY-ESO 1 137-151, LTAADHRQLQLSISS |
| SP-MHCI-1154-2 | NY-ESO 1 133-147, LTIRLTAADHRQLQL |
| SP-MHCI-1154-3 | NY-ESO 1 133-147, LTIRLTAADHRQLQL |
| SP-MHCI-1155-2 | NY-ESO 2 21-35, PGIPDGPGGNAGGPG |
| SP-MHCI-1155-3 | NY-ESO 2 21-35, PGIPDGPGGNAGGPG |
| SP-MHCI-1156-2 | NY-ESO 1 45-59, PRGAGAARASGPGGG |
| SP-MHCI-1156-3 | NY-ESO 1 45-59, PRGAGAARASGPGGG |
| SP-MHCI-1157-2 | NY-ESO 1 61-75, PRGPHGGAASGLNGC |
| SP-MHCI-1157-3 | NY-ESO 1 61-75, PRGPHGGAASGLNGC |
| SP-MHCI-1158-2 | NY-ESO 1 77-91, RCGARGPESRLLEFY |
| SP-MHCI-1158-3 | NY-ESO 1 77-91, RCGARGPESRLLEFY |
| SP-MHCI-1159-2 | NY-ESO 1 121-135, VLLKEFTVSGNILTI |
| SP-MHCI-1159-3 | NY-ESO 1 121-135, VLLKEFTVSGNILTI |
| SP-MHCI-1160-2 | Human DEP domain-containing protein 1A 294-302, EYYELFVNI |
| SP-MHCI-1160-3 | Human DEP domain-containing protein 1A 294-302, EYYELFVNI |
| SP-MHCI-1161-2 | Influenza A (strain A/New Zealand:South Canterbury/35/2000 H1N1) Hemagglutinin 127-136, SFERFEIFPK |
| SP-MHCI-1161-3 | Influenza A (strain A/New Zealand:South Canterbury/35/2000 H1N1) Hemagglutinin 127-136, SFERFEIFPK |
| SP-MHCI-1162-2 | Human Mesothelin 20-28, SLLFLLFSL |
| SP-MHCI-1162-3 | Human Mesothelin 20-28, SLLFLLFSL |
| SP-MHCI-1163-2 | Human MAGE 3 133-147, AEMLGSVVGNWQYFF |
| SP-MHCI-1163-3 | Human MAGE 3 133-147, AEMLGSVVGNWQYFF |
| SP-MHCI-1164-2 | Human MAGE 3 277-291, ALVETSYVKVLHHMV |
| SP-MHCI-1164-3 | Human MAGE 3 277-291, ALVETSYVKVLHHMV |
| SP-MHCI-1165-2 | Human MAGE 3 241-255, DPKKLLTQHFVQENY |
| SP-MHCI-1165-3 | Human MAGE 3 241-255, DPKKLLTQHFVQENY |
| SP-MHCI-1166-2 | Human MAGE 3 229-243, EVFEGREDSILGDPK |
| SP-MHCI-1166-3 | Human MAGE 3 229-243, EVFEGREDSILGDPK |
| SP-MHCI-1167-2 | Human MAGE 2 257-271, EYRQVPGSDPACYEF |
| SP-MHCI-1167-3 | Human MAGE 2 257-271, EYRQVPGSDPACYEF |
| SP-MHCI-1168-2 | Human MAGE 3 137-151, GSVVGNWQYFFPVIF |
| SP-MHCI-1168-3 | Human MAGE 3 137-151, GSVVGNWQYFFPVIF |
| SP-MHCI-1169-2 | Human MAGE 2 9-23, HCKPEEGLEARGEAL |
| SP-MHCI-1169-3 | Human MAGE 2 9-23, HCKPEEGLEARGEAL |
| SP-MHCI-1170-2 | Human MAGE 3 189-203, LLGDNQIMPKAGLLI |
| SP-MHCI-1170-3 | Human MAGE 3 189-203, LLGDNQIMPKAGLLI |
| SP-MHCI-1171-2 | Human MAGE 3 245-259, LLTQHFVQENYLEYR |
| SP-MHCI-1171-3 | Human MAGE 3 245-259, LLTQHFVQENYLEYR |
| SP-MHCI-1172-2 | Human MAGE 3 193-207, NQIMPKAGLLIIVLA |
| SP-MHCI-1172-3 | Human MAGE 3 193-207, NQIMPKAGLLIIVLA |
| SP-MHCI-1173-2 | Human MAGE 3 197-211, PKAGLLIIVLAIIAR |
| SP-MHCI-1173-3 | Human MAGE 3 197-211, PKAGLLIIVLAIIAR |
| SP-MHCI-1174-2 | Human MAGE 3 61-75, PPQSPQGASSLPTTM |
| SP-MHCI-1174-3 | Human MAGE 3 61-75, PPQSPQGASSLPTTM |
| SP-MHCI-1175-2 | Human MAGE 3 65-79, PQGASSLPTTMNYPL |
| SP-MHCI-1175-3 | Human MAGE 3 65-79, PQGASSLPTTMNYPL |
| SP-MHCI-1176-2 | Human MAGE 3 185-199, SYDGLLGDNQIMPKA |
| SP-MHCI-1176-3 | Human MAGE 3 185-199, SYDGLLGDNQIMPKA |
| SP-MHCI-1177-2 | Human MAGE 3 273-287, WGPRALVETSYVKVL |
| SP-MHCI-1177-3 | Human MAGE 3 273-287, WGPRALVETSYVKVL |
| SP-MHCI-1178-2 | Human MAGE 3 269-283, YEFLWGPRALVETSY |
| SP-MHCI-1178-3 | Human MAGE 3 269-283, YEFLWGPRALVETSY |
| SP-MHCI-1179-2 | NY-ESO 1 157-171, SLLMWITQCFLPVFL |
| SP-MHCI-1179-3 | NY-ESO 1 157-171, SLLMWITQCFLPVFL |
| SP-MHCI-1180-2 | Human Telomerase reverse transcriptase 572-580, YLFFYRKSV |
| SP-MHCI-1180-3 | Human Telomerase reverse transcriptase 572-580, YLFFYRKSV |
| SP-MHCI-1181-2 | NY-ESO 2 37-51, AGATGGRGPRGAGAA |
| SP-MHCI-1181-3 | NY-ESO 2 37-51, AGATGGRGPRGAGAA |
| SP-MHCI-1182-2 | NY-ESO 1 93-107, AMPFATPMEAELARR |
| SP-MHCI-1182-3 | NY-ESO 1 93-107, AMPFATPMEAELARR |
| SP-MHCI-1183-2 | NY-ESO 1 113-127, APPLPVPGVLLKEFT |
| SP-MHCI-1183-3 | NY-ESO 1 113-127, APPLPVPGVLLKEFT |
| SP-MHCI-1184-2 | NY-ESO 1 105-119, ARRSLAQDAPPLPVP |
| SP-MHCI-1184-3 | NY-ESO 1 105-119, ARRSLAQDAPPLPVP |
| SP-MHCI-1185-2 | NY-ESO 1 69-83, ASGLNGCCRCGARGP |
| SP-MHCI-1185-3 | NY-ESO 1 69-83, ASGLNGCCRCGARGP |
| SP-MHCI-1186-2 | NY-ESO 1 97-111, ATPMEAELARRSLAQ |
| SP-MHCI-1186-3 | NY-ESO 1 97-111, ATPMEAELARRSLAQ |
| SP-MHCI-1187-2 | NY-ESO 1 141-155, DHRQLQLSISSCLQQ |
| SP-MHCI-1187-3 | NY-ESO 1 141-155, DHRQLQLSISSCLQQ |
| SP-MHCI-1188-2 | NY-ESO 1 125-139, EFTVSGNILTIRLTA |
| SP-MHCI-1188-3 | NY-ESO 1 125-139, EFTVSGNILTIRLTA |
| SP-MHCI-1189-2 | NY-ESO 1 96-104, FATPMEAEL |
| SP-MHCI-1189-3 | NY-ESO 1 96-104, FATPMEAEL |
| SP-MHCI-1190-2 | NY-ESO 1 166-180, FLPVFLAQPPSGQRR |
| SP-MHCI-1190-3 | NY-ESO 1 166-180, FLPVFLAQPPSGQRR |
| SP-MHCI-1191-2 | NY-ESO 2 13-27, GDADGPGGPGIPDGP |
| SP-MHCI-1191-3 | NY-ESO 2 13-27, GDADGPGGPGIPDGP |
| SP-MHCI-1192-2 | NY-ESO 2 29-43, GNAGGPGEAGATGGR |
| SP-MHCI-1192-3 | NY-ESO 2 29-43, GNAGGPGEAGATGGR |
| SP-MHCI-1193-2 | NY-ESO 2 33-47, GPGEAGATGGRGPRG |
| SP-MHCI-1193-3 | NY-ESO 2 33-47, GPGEAGATGGRGPRG |